All In Biotech

Free tool

FAERS Monitor: Ultravist 150

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020220 or its brand name (Ultravist 150, Iopromide). Reports on generic versions are filed under their own applications.

Reports

4,182

Serious

3,709

89% of reports

Hospitalization

1,357

Death reported

336

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea621
  • urticaria545
  • pruritus481
  • erythema394
  • anaphylactic shock389
  • blood pressure decreased376
  • nausea320
  • vomiting293
  • loss of consciousness255
  • oxygen saturation decreased248
  • dizziness230
  • rash228
  • contrast media allergy214
  • hypotension193
  • chest discomfort180

Reports by year received

View as table
YearReports
20041
20057
20061
20073
200813
200929
201015
201117
2012103
2013194
2014208
2015231
2016239
2017203
2018229
2019198
2020282
2021176
2022279
2023413
2024493
2025456
2026392

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,977 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contrast media allergySignal214665.3578.8124,804
anaphylactic shockSignal38977.170.028,721
blood pressure decreasedSignal37628.626.09,967
oxygen saturation decreasedSignal24822.319.75,012
urticariaSignal54516.415.27,910
loss of consciousnessSignal25510.08.92,072
erythemaSignal3949.78.83,073
chest discomfortSignal1808.97.71,250
pruritusSignal4816.35.82,177
dyspnoeaSignal6215.55.12,356
hypotensionSignal1934.84.2590
vomitingSignal2933.12.8433
rashSignal2282.62.3234
dizzinessSignal2302.32.0175
nauseaSignal3202.01.8174

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.